Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a short daily workout help hospitalized diabetes patients?

NCT ID NCT06547541

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether hospitalized adults with type 2 diabetes or prediabetes could safely do 30 minutes of resistance training each day. The goal was to see if this exercise routine is feasible and if it helps control blood sugar and prevent muscle loss during a hospital stay. Only 4 people took part before the study was stopped early, so the results are very limited.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
resistance training (body weight exercises)
What this could lead to
If successful, this could show that simple in-hospital exercise helps manage blood sugar and muscle loss in type 2 diabetes patients.
What could go wrong
This is a very small, early feasibility study (only 4 participants enrolled) and was terminated early, so results are limited and may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

4 people

The number who actually took part.

Started

Aug 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * T2D or prediabetes defined as at least one of the following * ICD-10 diagnosis of T2D (DE11.x) * HbA1c \> 48 at time of admission * Use of type 2 antidiabetic medicine (excluding SGLT2 inhibitors) * HbA1c ≥ 42 within 3 months of admission (prediabetes) (from 18 of September, 2024) * Hospitalized with an infection * Expected residual hospitalization time of at least three days * At least 18 years of age * Able to perform exercises in the booklet "Syg men sun dog aktiv" Exclusion Criteria: * Admitted to the hospital more than 5 days ago * Unable to give written consent to participate * Terminal illness * Unstable or new onset angina * Ventricular arrhythmia * Aortic stenosis * Sternotomy in conjunction with the current hospitalization * Blood pressure greater than 180/120 mmHg * Kidney failure requiring dialysis * Unable to follow the 3-stage command of the Mini-Mental State Examination * Known allergy or contact dermatitis to tape, and CGMs

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus type 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Copenhagen University Hospital

    Copenhagen, Capitol Region of Denmark, 2100, Denmark

  • Departement of Infectious Diseases - Hvidovre Hospital

    Copenhagen, Capitol Region of Denmark, 2650, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.